Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 17,759 | 14,248 | 12,247 | 10,439 | 10,353 |
| Cost of Goods | 2,950 | 3,205 | 2,695 | 2,045 | 2,278 |
| Gross Profit | 14,809 | 11,043 | 9,552 | 8,394 | 8,075 |
| Operating Expenses | 13,559 | 12,792 | 16,086 | 13,973 | 12,025 |
| Operating Income | 2,200 | -1,544 | -5,839 | -5,534 | -3,672 |
| Other Income | -1,909 | -2,016 | -1,904 | -1,730 | -1,762 |
| Pre-tax Income | 291 | -3,560 | -7,743 | -7,264 | -5,434 |
| Net Income Continuous | 291 | -3,560 | -7,743 | -7,264 | -5,434 |
| Net Income | $291 | $-3,560 | $-7,743 | $-7,264 | $-5,434 |
| EPS Basic Total Ops | 0.03 | -0.24 | -0.52 | -0.50 | -0.30 |
| EPS Basic Continuous Ops | 0.02 | -0.24 | -0.52 | -0.49 | -0.36 |
| EPS Diluted Total Ops | 0.03 | -0.24 | -0.52 | -0.50 | -0.30 |
| EPS Diluted Continuous Ops | 0.02 | -0.24 | -0.52 | -0.49 | -0.36 |
| EBITDA(a) | $3,406 | $-361 | $-4,729 | $-4,425 | $-2,572 |